Company Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.
The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.
It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards.
The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
| Country | United States |
| Founded | 1996 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 287 |
| CEO | Sandra Campos |
Contact Details
Address: 420 South Congress Avenue Delray Beach, Florida 33445 United States | |
| Phone | 561 526 4444 |
| Website | 1800petmeds.com |
Stock Details
| Ticker Symbol | PETS |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001040130 |
| CUSIP Number | 716382106 |
| ISIN Number | US7163821066 |
| Employer ID | 65-0680967 |
| SIC Code | 5912 |
Key Executives
| Name | Position |
|---|---|
| Sandra Y. Campos | President, Chief Executive Officer and Director |
| Christine Chambers | Chief Financial Officer, Principal Financial Officer, Treasurer and Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 12, 2024 | 8-K | Current Report |
| Aug 8, 2024 | 8-K | Current Report |
| Aug 8, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Aug 7, 2024 | 10-Q | Quarterly Report |
| Aug 6, 2024 | 8-K | Current Report |
| Aug 5, 2024 | 8-K | Current Report |
| Jul 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jul 2, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 24, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 24, 2024 | DEF 14A | Other definitive proxy statements |